Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2025-02-28 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
关于控股股东、实际控制人部分股份质押及解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by a controlling shareholder and actual controller of the company. It details the number of shares pledged, released, and the related terms, including dates and pledgees. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledging activities by a major shareholder, which fits the category of Major Shareholding Notification (MRQ). The document length is short (1932 characters), and it is not an announcement of a report publication but a direct disclosure of share pledge information. Therefore, the appropriate classification is MRQ with high confidence.
2025-02-28 Chinese
华泰联合证券有限责任公司关于南京药石科技股份有限公司部分募集资金投资项目调整实施地点、内部投资构成暨延期的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from Huatai United Securities Co., Ltd. regarding the adjustment of implementation locations, internal investment structure, and delay of certain fundraising investment projects of Nanjing Yaoshi Technology Co., Ltd. It includes specifics about the 2020 private placement fundraising, usage of funds, project progress, board and supervisory committee approvals, and the sponsor's verification opinion. The content focuses on the management and use of raised funds, project adjustments, and compliance with regulatory requirements. It is not a full annual or interim financial report, nor an earnings release or call transcript. It is not a simple announcement or certification but a substantive report on fundraising project adjustments and related approvals. This fits the category of Capital/Financing Update (CAP), as it deals with updates on company fundraising and capital use.
2025-02-17 Chinese
关于部分募集资金投资项目调整实施地点、内部投资构成暨延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding adjustments to the implementation location, internal investment structure, and extension of timelines for certain projects funded by previously raised capital. It references specific board and supervisory meetings approving these changes, details on the use of funds raised in 2020, and compliance with regulatory guidelines related to the management and use of raised funds. The document does not contain full financial statements or comprehensive financial performance data but focuses on updates about capital use and project adjustments. This fits the description of a Capital/Financing Update (CAP) as it provides updates on the use and management of raised capital and changes to investment projects funded by that capital.
2025-02-17 Chinese
第四届监事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the second meeting of the fourth Supervisory Board of Nanjing Yaoshi Technology Co., Ltd. It details the meeting's procedural compliance, voting results, and decisions regarding adjustments to investment projects. There is no financial data, no detailed report, nor is it a presentation or transcript. It is a regulatory announcement about board-level decisions, specifically from the Supervisory Board, which is part of management/board information disclosures. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, classification as MANG is appropriate with high confidence.
2025-02-17 Chinese
第四届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's fourth board of directors' second meeting. It includes details about the meeting's convening, attendance, and voting results on specific proposals related to investment project adjustments. There is no financial data, no detailed report content, and the document is relatively short (716 characters). It is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG).
2025-02-17 Chinese
关于2024年第四季度可转债转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Nanjing PharmaBlock Technologies about the convertible bond conversion situation for the fourth quarter of 2024. It details the number of convertible bonds converted into shares, the remaining convertible bonds, and changes in share capital. It references regulatory approvals, bond issuance details, bond conversion price adjustments, and shareholding changes. The document is relatively short (3556 characters) and primarily provides factual updates on convertible bond conversions and share capital changes without presenting comprehensive financial statements or analysis. This type of document is a capital/financing update regarding convertible bonds and share capital changes rather than a full financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-01-02 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.